Company Profile

SMS LIFESCIENCES INDIA LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE998.75129.5 (+14.9 % )
PREV CLOSE (Rs.) 869.25
OPEN PRICE (Rs.) 884.60
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 11824
TODAY'S LOW / HIGH (Rs.)884.60 1022.50
52 WK LOW / HIGH (Rs.)470.1 885.8
NSE997.05 126.35 (+14.51 % )
PREV CLOSE(Rs.) 870.70
OPEN PRICE (Rs.) 889.90
BID PRICE (QTY) 997.05 (180 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 153135
TODAY'S LOW / HIGH(Rs.) 875.70 1024.90
52 WK LOW / HIGH (Rs.)469.75 885.65

Company News

Date Heading Details
29-Sep-2021 Update On Subsidiary (Mahi Drugs) Mr. Venkata Chaitanya Gopineedi has been appointed as Director in the Board of the Mahi Drugs Private Limited (wholly owned subsidiary of the Company), in the Executive category, in the 9''" Annual General Meeting held today (i.e. September 28, 2021).
28-Sep-2021 SMS Lifesciences India informs about closure of trading window <p align="justify">SMS Lifesciences India has informed that the trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and Subsidiaries of the Company shall remain closed with effect from October 1, 2021 fill 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2021, in terms of the Code of Conduct of the Company.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
03-Sep-2021 Appointment of Director inter alia,approved: 1. Appointment of Mrs. Sudeepthi Gopin eedi as Additional Director (Executive category). 2. Resignation of Mrs. Neelaveni Thummala as Independent Director with immediate effect 3. Board Report for the ye ar ended March 31. 2021. 4. Holding the 15th Annual general meeting on September 30. 2021. though Video conferencing mode. pursuant to guidelines issued by SEBI and MCA.
03-Sep-2021 Resignation of Director inter alia,approved: 1. Appointment of Mrs. Sudeepthi Gopin eedi as Additional Director (Executive category). 2. Resignation of Mrs. Neelaveni Thummala as Independent Director with immediate effect 3. Board Report for the ye ar ended March 31. 2021. 4. Holding the 15th Annual general meeting on September 30. 2021. though Video conferencing mode. pursuant to guidelines issued by SEBI and MCA.
27-Aug-2021 Board Meeting Intimation for Considering Annual Report (F21) & AGM Date. SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2021 ,inter alia, to consider and approve We would like to inform you that the meeting of the Board of Directors of the Company has been scheduled to be held on Thursday, September 2, 2021, inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors.
27-Aug-2021 Appointment of Director Inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors.
09-Aug-2021 Board Meeting Intimation for Considering Financial Results Of Quarter Ended June 30, 2021. SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve i) Unaudited financial results (Standalone a nd Consolidated) of the Company for the first quarter ended June 30, 2021 . ii) The request received from Promoter/Promoter Group regarding reclassification to Public category pursuant to Regulation 31 (A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. iii) any other items as may be decided by the Board of Directors.
19-Jun-2021 SMS Lifesciences India informs about reappointment of auditor(s) <p align="justify">SMS Lifesciences has informed that the Board of Directors of the Company, at its Meeting held yesterday June 18, 2021 has approved the reappointment of following Auditors: Statutory Auditors for the Second Term of 5 (five) years, Secretarial Auditors for the year 2021-22; and Cost Auditors for the year 2021-22.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
19-Jun-2021 SMS Lifesciences India informs about resignation of director <p align="justify">SMS Lifesciences India has informed that Ramesh Babu Potluri has conveyed his decision to resign from the position of Non-Executive Director of the Company with immediate effect. The Board of Directors approved the same with effect from the close of business hours on June 18, 2021.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
01-Jun-2021 SMS Lifesciences India informs about board meeting <p align="justify">SMS Lifesciences India has informed that the meeting of the Board of Directors of the Company has been scheduled to be held on Monday, June 7, 2021, to consider and approve the audited financial results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021. Pursuant to SEBI (Listing Obligations and Disclosure Requirements) (Second Amendment) Regulations, 2021, the requirement of newspaper advertisement for intimation of Board Meeting has been omitted. Further, in continuation to letter dated March 29, 2021 and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in the securities of the Company shall remain closed for all the Designated Persons and their Immediate Relatives till 48 hours from the closure of the Board Meeting.</p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>